Safety and tolerability of MEDI9314 as single ascending dose in healthy subjects

Trial Identifier: D4361C00002
Sponsor:MedImmune, LLC
Start Date:February 2016
Primary Completion Date: November 2016
Study Completion Date: June 2017
Condition: Healthy Volunteers; Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

English translation
Japanese translation

Trial Locations

United Kingdom Harrow, United Kingdom, HA1 3UJ
United States of America, CA Glendale, CA, United States of America, 91206